KAMPALA, Nov. 30 (Xinhua) -- Uganda is scheduled to start trials of three antiviral drugs developed locally to cure COVID-19, the country's president Yoweri Museveni said here late on Sunday.
Museveni in a televised address said trials of the drugs developed by local scientists will start on December 15 and will run for 40 days.
He said studies on COVID-19 patients treated from home show that the antiviral drugs kill the virus and also limit the damage the virus does on the body.
"The scientists have told me that dozens of people have been healed by these substances but, starting December 15, patients, under strict medical supervision, will have this medicine tried on them," the president said.
"The scientists are saying that within 40 days, enough patients will have been treated, to convince the other persons that are not part of the trials that the drug works against the corona and other viruses," he added.
Museveni urged the public not to be complacent, warning that the virus is still killing people.
As of Sunday, Uganda had registered a cumulative number of 20,145 COVID-19 cases, 8,989 recoveries, and 201 deaths since the first case was reported on March 21 in the country, according to the ministry of health. Enditem
